340B Unscripted

Ep 15 | Building Your 340B Team

In this episode, Rob and Greg are joined by pharmacist leader and 340B expert Leah Marcelin (22:32) to share thoughts and ideas about building out an expert staff to manage your 340B program. They’ll debate strategies for right-sizing and organizing your team, share tips on recruiting 340B talent, and offer ideas on how to provide training and enrichment to 340B team staff members. But first, Rob and Greg spend some time discussing a new organization - ASAP 340B, and their advocacy campaign prop...

Ep 14 | All About 340B Grantees (Part 2)

This is part two of our two-part series focusing on 340B grantee-covered entities. The team talks about the importance of maintaining auditable records (15:34) and the challenges that many grantees face in meeting this 340B eligibility requirement. Also, they cover important billing considerations related to Medicaid Duplicate Discount prevention (31:20). Finally, the group debates future developments that 340B grantee-covered entities should keep on their radar through 2023 (45:52). But first, ...

Ep 14 | All About 340B Grantees (Part 1)

This episode is the first part of a two-part series focusing on 340B grantee-covered entities. Rob and Greg are joined by SpendMend pharmacy experts (19:43) who bring their FQHC and Ryan White experience to share insights into 340B Program participation from the grantee perspective. They’ll discuss what to look out for regarding OPAIS registrations (21:00) and requirements for using 340B savings (33:11). But first, Rob and Greg catch up on the latest 340B developments, including new J&J cont...

Ep 13 | Update on Manufacturer Restrictions for 340B Contract Pharmacies

In this episode, Rob and Greg catch up on recent 340B developments, including the 3rd Circuit Court ruling on one of the contract pharmacy cases and the subsequent changes to some manufacturer's policies (1:36), how the new shape of the Senate HELP Committee may influence 340B legislative debate, and why a renewed focus on advocacy might be helpful (9:39) and what the end of the COVID-19 Public Health Emergency (PHE) might mean for 340B Program operations (15:54). Later, Rob and Greg are joined ...

Ep 12 | Pharmacy Benefit Optimization for 340B Covered Entities

Rob and Greg kick off the episode with some discussion around news and noteworthy items across the 340B landscape, including more dialogue around CMS guidance on “JG”/”TB” modifiers (1:01), 340B in the news media (4:31), grantee recertification tips (14:13) and ongoing challenges working 340B ESP (18:39). Later in the episode, they are joined by Victoria Ferris of OptumRx and Thatcher Sloan of RxBenefits to discuss pharmacy benefit strategy as an underappreciated opportunity in the 340B space (2...

Ep 11 | Trends in Direct Order Procurement

Ep 10 | Top 10 Developments in 340B for 2022

For our last episode of 2022 Rob and Greg are joined again by SpendMend colleague Matt Parker and debate the top developments in the 340B space over the last year.

Ep 9 | TPA Transition Tips and Tricks

In this episode, we have podcast guests Anna Bulochnik, and Chelsea Violette to discuss the challenging task of switching third-party administrators (TPAs). Great tips and recommendations on how to make the transition as smooth as possible.

Ep 8 | Trulla - Modernizing Pharmacy Procurement

On this episode, Rob and Greg welcome a few new SpendMend colleagues - Curtis McEntire and Angela Whitney– to talk about Trulla, a state-of-the-art pharmacy procurement solution now offered by SpendMend. They’ll talk about the challenges of today’s pharmacy buyer, common untapped opportunities for drug savings, and how Trulla can bring your pharmacy procurement process into the future.

Ep 7 | Don’t be Haunted by a HRSA Audit!

It’s Halloween, and in this episode, Greg and Rob invite guests from the field to discuss “tricks and treats” from recent HRSA audit experiences! They’ll review strategies for gathering audit data, the coaching staff for the onsite visit, and what you need to consider when you eventually receive your final audit report. HRSA audits can be a “frightening” experience, but this conversation will give you lots of info to help you be ready! Also, the guys share updates on CMS OPPS payments for 340B h...

Ep 6 | 340B NYT Article: Are You Next?

In this episode, Rob and Gren welcome William Mayhood to the Pod and get into the New York Times article on Bon Secours’ 340B program. We shift gears and get into what covered entities should be doing in preparation for a similar media article, or congressional inquiry, and bring back the 340B Impact Statement. You never know, your CE could be next!

Ep 5 | Weighing the Risk: Referral Capture vs. Continuum of Care

In this episode, Greg and Rob are joined by another SpendMend Pharmacy colleague – Riley Protz, who serves as Director of Optimization. They discuss the impact of referral capture opportunities on 340B Program participation and debate the risks of this strategy in comparison with other strategies, like the application of the “continuum of care” in the patient definition.

Ep 4 | Inflation Reduction Act’s 340B Impact

In Episode 4 of the 340B Unscripted podcast, Greg and Rob bring on Matt Parker, VP of Optimization and Growth at SpendMend AND the maestro behind the scenes of the podcast, to discuss the Inflation Reduction Act and how it impacts 340B. We discuss both the inflation penalty impact starting in 2023 and the negotiated Medicare pricing impact that starts in 2026.

Ep 3 | Future Outlook of 340B Contract Pharmacy Limitations

In this episode, Greg and Rob are joined by SpendMend colleague Jacob Thompson to discuss the future outlook of the 340B Contract Pharmacy Limitations. They review past 340B/CMS litigation that ultimately ended at the Supreme Court. From that review, they predict the path and length of time these limitations are most likely in place. This is a very important topic as CEs navigate if they should submit data to 340B ESP.

Ep 2 | 2022 340B Coalition Summer Recap

In this episode, Greg and Rob are back from Washington, D.C., and are joined by SpendMend colleague Jennifer Hagen to recap highlights from the 2022 Summer 340B Coalition Conference. They dig into lessons learned from various sessions at the conference and chat about HRSA audit trends, operational challenges from recent manufacturer restrictions, as well as “big picture” considerations for 340B covered entities for the remainder of 2022. Also, stick around at the end of the episode to hear sound...

Ep 1 | 340B Patient Definition Roundtable

Ep 0 | 340B Unscripted